Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-007888
Filing Date
2004-03-15
Accepted
2004-03-15 12:17:19
Documents
9
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2128974z10-k.htm 10-K 780805
3 EXHIBIT 10.39 a2128974zex-10_39.htm EX-10.39 60294
4 EXHIBIT 10.40 a2128974zex-10_40.htm EX-10.40 58066
5 EXHIBIT 10.42 a2128974zex-10_42.htm EX-10.42 25999
6 EXHIBIT 10.43 a2128974zex-10_43.htm EX-10.43 7244
7 EXHIBIT 23.1 a2128974zex-23_1.htm EX-23.1 1795
8 EXHIBIT 31.1 a2128974zex-31_1.htm EX-31.1 6375
9 EXHIBIT 31.2 a2128974zex-31_2.htm EX-31.2 6376
10 EXHIBIT 32 a2128974zex-32.htm EX-32 3204
  Complete submission text file 0001047469-04-007888.txt   952595
Mailing Address
Business Address 6611 DUMBARTON CIRCLE FREMONT CA 94555 5105052100
CIPHERGEN BIOSYSTEMS INC (Filer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31617 | Film No.: 04668449
SIC: 3826 Laboratory Analytical Instruments